Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  RHÖN-KLINIKUM Aktiengesellschaft    RHK   DE0007042301

RHÖN-KLINIKUM AKTIENGESELLSCHAFT

(RHK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

RHÖN-KLINIKUM Aktiengesellschaft: Management proposes full retention of 2019 net profits; virtual annual general meeting on 19 August 2020

share with twitter share with LinkedIn share with facebook
07/09/2020 | 06:50am EDT

DGAP-Ad-hoc: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Dividend/AGM/EGM
RHÖN-KLINIKUM Aktiengesellschaft: Management proposes full retention of 2019 net profits; virtual annual general meeting on 19 August 2020

09-Jul-2020 / 12:46 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of insider information according to Article 17 EU Market Abuse Regulation (MAR)

RHÖN-KLINIKUM Aktiengesellschaft: Management proposes full retention of 2019 net profits; virtual annual general meeting on 19 August 2020

Bad Neustadt a. d. Saale, 9 July 2020. Today, the management board and supervisory board of RHÖN-KLINIKUM Aktiengesellschaft have unanimously approved an amendment of the proposal for the distribution of profits of the 2019 financial year. Following the ad hoc notice by RHÖN-KLINIKUM Aktiengesellschaft dated 16 May 2020 announcing that the initial proposal for a dividend payment of EUR 0.25 per dividend-bearing share would be reviewed because of the ongoing COVID-19 pandemic, management board and supervisory board now propose to fully retain the annual profit of EUR 203,529,952.42 because of the continuing uncertainties regarding the effects of the COVID-19 pandemic and the additional financial impact of the public takeover offer on profitability and liquidity of the company. The retention of the annual profit seeks to strengthen the capital and liquidity base and to maintain RHÖN-KLINIKUM Aktiengesellschaft's investment capability.

The annual general meeting 2020, at which a resolution on the proposal for the distribution of profits for the 2019 financial year is to be passed, will be held as a virtual general meeting on 19 August 2020.

Bad Neustadt a. d. Saale, 9 July 2020.

Your contact:

RHÖN-KLINIKUM AG |Head of Investor Relations and Treasury
Julian Schmitt
T. +49 9771 65-12250 | julian.schmitt@rhoen-klinikum-ag.com
(notifying person)

RHÖN-KLINIKUM AG |Head of Corporate Communications and Marketing
Elke Pfeifer
T. +49 9771 65-12110 | elke.pfeifer@rhoen-klinikum-ag.com


09-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: RHÖN-KLINIKUM Aktiengesellschaft
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1090073

 
End of Announcement DGAP News Service

1090073  09-Jul-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1090073&application_name=news&site_id=zonebourse

© EQS 2020
share with twitter share with LinkedIn share with facebook
All news about RHÖN-KLINIKUM AKTIENGESELLSCHAFT
02:05aRHÖN KLINIKUM AKTIENG : sellschaft sells shares in Medgate Deutschland GmbH
EQ
09/07RHÖN-KLINIKUM AKTIENGESELLSCHAFT : Partnership with Asklepios Strengthens Medica..
EQ
08/19RHÖN-KLINIKUM AKTIENGESELLSCHAFT : Annual General Meeting resolves to retain net..
EQ
08/11RHÖN KLINIKUM : Supervisory Board of RHÖN-KLINIKUM AG Appoints Two New Members t..
EQ
08/06RHÖN KLINIKUM : concludes the first six months of 2020 with increased revenues -..
EQ
07/29RHÖN-KLINIKUM AG : Release according to Article 40, Section 1 of the WpHG [the G..
EQ
07/23RHÖN-KLINIKUM AG : Release according to Article 40, Section 1 of the WpHG [the G..
EQ
07/15RHÖN-KLINIKUM AG : Release according to Article 40, Section 1 of the WpHG [the G..
EQ
07/09RHÖN-KLINIKUM AKTIENGESELLSCHAFT : Management Board of RHÖN-KLINIKUM AG Welcomes..
EQ
07/09RHÖN-KLINIKUM AKTIENGESELLSCHAFT : Management proposes full retention of 2019 ne..
EQ
More news
Financials
Sales 2020 1 354 M 1 575 M 1 575 M
Net income 2020 34,3 M 39,9 M 39,9 M
Net Debt 2020 - - -
P/E ratio 2020 31,5x
Yield 2020 1,88%
Capitalization 1 071 M 1 248 M 1 246 M
Capi. / Sales 2020 0,79x
Capi. / Sales 2021 0,75x
Nbr of Employees 18 131
Free-Float 20,5%
Chart RHÖN-KLINIKUM AKTIENGESELLSCHAFT
Duration : Period :
RHÖN-KLINIKUM Aktiengesellschaft Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RHÖN-KLINIKUM AKTIENGESELLSCHAFT
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 18,00 €
Last Close Price 16,00 €
Spread / Highest target 12,5%
Spread / Average Target 12,5%
Spread / Lowest Target 12,5%
EPS Revisions
Managers
NameTitle
Stephan Holzinger Chairman-Management Board
Eugen Münch Chairman-Supervisory Board
Gunther K. Weiß Chief Operating Officer & Member-Management Board
Wolfgang Mündel Second Deputy Chairman-Supervisory Board
Gerhard Ehninger Member-Supervisory Board